Chris Bowden, Managing Director at Squeaky, outlines how the c-suite can walk-the-walk on climate change and the challenges leaders are facing in the race to net-zero.
Sarah Stone, Director of Samtaler, explores how the new Central Government Social Value Model can be used as a strong commercial driver for all organisations to develop a cohesive and more strategic Social Value offer.
Richard Farrell, Chief Innovation Officer at Netcall, talks about the challenges that local councils have faced and the role that low-code technology can and should play in enabling local authorities to guide and support citizens.
In February, 16% of the world's population pre-ordered 70% of available COVID vaccines - now, researchers at Colombia University reveal that some poorer countries won't be able to vaccinate their population until 2023.
Adam Maddison, director of client services at dxw, analyses the recent government Green Paper on transforming public procurement, focussing heavily on the support available to SMEs.
Reaching the net zero targets announced by countries around the world isn't just about generating cleaner energy: it will also require significant improvements in making our energy use more efficient.
Sayantan Ghosal, Adam Smith Chair in Political Economy, discusses an often-overlooked policy question: What is the relationship between aspiration failure and the continuation of poverty?
When rethinking service transformation, the focus should be on reshaping - Christopher Sly, AVP, Digital Transformation, HGS UK, explains why knowing the limitations to emerging tech reshapes a far greater value story.
Rob Walton, Industry Director - Public Sector, Six Degrees, discusses how the public sector must rebuild trust by implementing robust and flexible data security infrastructure.
Here, the team at SafeSite Security Solutions talk about Empty Property Rates and the recent decision by the Court of Appeal to dismiss a public interest challenge to a Government scheme for the mitigation of business rates on empty property.
EU leaders today (25 March) decided not to create an export ban for AstraZeneca vaccines made for the UK - but the feud between AstraZeneca and the bloc remains close to the surface of future discussions.
